How to manage hypotension in a patient with dengue fever?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 3, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Management of Hypotension in Dengue Fever

For dengue shock syndrome with hypotension, immediately administer 20 mL/kg of isotonic crystalloid (Ringer's lactate or 0.9% normal saline) as a rapid bolus over 5-10 minutes, with immediate reassessment after each bolus and readiness to repeat up to 40-60 mL/kg in the first hour before escalating to vasopressors. 1

Initial Fluid Resuscitation Protocol

Crystalloid resuscitation is first-line therapy and achieves near 100% survival when properly administered in dengue shock syndrome. 1

  • Administer the initial 20 mL/kg bolus over 5-10 minutes using isotonic crystalloid (Ringer's lactate or 0.9% normal saline) 1, 2
  • Reassess immediately after each bolus for signs of improvement: decreased tachycardia, decreased tachypnea, improved capillary refill, warming of extremities, improved mental status, and adequate urine output 1, 2
  • If shock persists after the initial bolus, repeat crystalloid boluses up to a total of 40-60 mL/kg in the first hour 1, 2
  • Delaying fluid resuscitation in established dengue shock syndrome significantly increases mortality, as cardiovascular collapse may rapidly follow once hypotension occurs 1

When to Escalate to Colloids

  • Consider switching to colloid solutions (albumin, gelafundin, or dextran) if shock persists despite adequate crystalloid resuscitation or if pulse pressure is <10 mmHg 1, 3
  • Moderate-quality evidence shows colloids achieve faster resolution of shock (RR 1.09,95% CI 1.00-1.19) and reduce total volume needed (mean 31.7 mL/kg versus 40.63 mL/kg for crystalloids) 1
  • However, clinical outcomes (mortality) are similar between crystalloids and colloids when properly administered 1

Vasopressor Therapy for Refractory Shock

If shock persists despite 40-60 mL/kg of crystalloid in the first hour, switch strategy from aggressive fluid administration to inotropic support rather than continuing fluid boluses. 1, 2

  • For cold shock (poor perfusion, cold extremities) with hypotension: titrate epinephrine as first-line vasopressor 1, 2
  • For warm shock (bounding pulses, warm extremities) with hypotension: titrate norepinephrine as first-line vasopressor 4, 1, 2
  • Target mean arterial pressure appropriate for age and maintain ScvO2 >70% 1
  • Begin peripheral inotropic support immediately if central venous access is not readily available, as delays in vasopressor therapy are associated with major increases in mortality 1

Critical Monitoring Parameters During Resuscitation

  • Watch for signs of adequate tissue perfusion: normal capillary refill time (<2 seconds), absence of skin mottling, warm and dry extremities, well-felt peripheral pulses, return to baseline mental status, and adequate urine output (>0.5 mL/kg/hour in adults) 1, 2
  • Monitor hematocrit closely: rising hematocrit indicates ongoing plasma leakage and need for continued resuscitation, while falling hematocrit suggests successful plasma expansion 1, 2
  • Stop fluid resuscitation immediately if signs of fluid overload develop: hepatomegaly, pulmonary rales, or respiratory distress 1, 5

Critical Pitfalls to Avoid

  • Do NOT give routine bolus IV fluids to patients with dengue fever who are NOT in shock - this increases fluid overload and respiratory complications without improving outcomes 1, 6
  • Do NOT continue aggressive fluid resuscitation once signs of fluid overload appear - switch to inotropic support instead 1, 2
  • Do NOT use restrictive fluid strategies in established dengue shock syndrome - moderate-quality evidence shows no survival benefit from colloid restriction, and aggressive fluid management achieves near 100% survival 1
  • Do NOT delay vasopressor initiation if shock persists despite adequate fluid resuscitation - delays are associated with major increases in mortality 1
  • Blood pressure alone is not a reliable endpoint in children, as hypotension is a late finding 1

Special Considerations

  • Myocardial dysfunction may contribute to persistent hypotension in some patients despite adequate hydration - consider echocardiography if hypotension persists despite appropriate fluid resuscitation 7
  • In resource-rich settings with persistent shock, consider invasive monitoring (central venous pressure, arterial line) to guide therapy 1
  • After initial shock reversal, judicious fluid removal may be necessary during the recovery phase - evidence shows that aggressive shock management followed by fluid removal decreased pediatric ICU mortality from 16.6% to 6.3% 1
  • Consider continuous renal replacement therapy (CRRT) if fluid overload >10% develops, as outcomes are better when CRRT is initiated early 1

Supportive Care

  • Use acetaminophen only for pain and fever management - never use aspirin or NSAIDs due to increased bleeding risk 1, 3, 2
  • Blood transfusion may be necessary for significant bleeding - target hemoglobin >10 g/dL if ScvO2 <70% 1, 2
  • Maintain adequate oxygenation and consider higher packed cell volume targets to ensure adequate tissue perfusion during shock 8

References

Guideline

Dengue Treatment Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Dengue Fluid Management

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Dengue Fever Management Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

FLUID AND HEMODYNAMIC MANAGEMENT IN SEVERE DENGUE.

The Southeast Asian journal of tropical medicine and public health, 2015

Research

Myocardial dysfunction in children with dengue haemorrhagic fever.

The National medical journal of India, 1998

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.